Congestive Heart Failure Congestive Heart Failure Results from any structural or functional disorder that impairs the ability of the ventricle to contract and effectively pump blood to meet the metabolic needs of the tissue ID: 532768
Download Presentation The PPT/PDF document "Jennifer Smith & Kelly Strine" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Jennifer Smith & Kelly Strine
Congestive Heart FailureSlide2
Congestive Heart Failure
Results from any structural or functional disorder that impairs the ability of the ventricle to contract and effectively pump blood to meet the metabolic needs of the tissue.
Affects the cardiovascular and pulmonary system
Associated with a hypercoagulable stateIncreased trend of heart failure with preserved ejections fraction of 50% or higherClassified as “diastolic”(preserved ejection fraction) or “systolic” (reduced ejection fractionPatients may have both diastolic and systolic dysfunction
(
Dunphy
,
Winland
-Brown, Porter & Thomas, 2011)Slide3
NYHA Functional Classifications
Class I: No limitation of physical activity; ordinary physical activity does not cause undue fatigue, palpitations, or dyspnea
Class II: Slight limitation of physical activity; comfortable at rest, but ordinary activity results in fatigue, palpitations, or dyspnea
Class III: Marked limitation of physical activity; comfortable at rest, but less than ordinary activity results in fatigue, palpitations, or dyspneaClass IV: Unable to carry on any physical activity without discomfort; symptoms present at rest if any activity is undertaken, discomfort is increased
(McMurray, 2010)Slide4
Pathophysiology
Myocardial injury leads to pathologic remodeling of left ventricle affecting its size, shape, and function impairing its contraction
Neurohumoral
imbalance, increased cytokines, and inflammatory changesApoptosis results in energy starvation and oxidative stressTissue hypoperfusionElevated levels of norepinephrine, angiotensin II, aldosterone, endothelin, vasopressin, and cytokinesInadequate delivery of oxygenResults in pulmonary and systemic venous hypertension
Progressively worse if left untreated
Exacerbated by additional injury (e.g. myocardial infarction)
Sympathetic Stimulation- increased heart rate
Activation of renin-angiotensin-aldosterone system
Hypertrophy
(McMurray, 2010) Slide5
Etiology
Coronary Heart Disease
Myocardioal
InfactionHypertensionDiabetesCardiomyopathyValvular DiseaseArrhythmiasCongenital Heart DefectsThyroid DisordersAlcohol/Cocaine or other Drug use
(
Dunphy
,
Winland
-Brown, Porter & Thomas, 2011)Slide6
Pathophysiology
Systolic Dysfunction
Forward Heart Failure
Diastolic DysfunctionBackward Heart FailureLeft Sided Heart FailureRight Sided Heart Failure
(
Dunphy
,
Winland
-Brown, Porter & Thomas, 2011)Slide7
Incidence
Affects approximately 5 million in U.S.
Over 550,000 diagnosed each year
Primary reason for 12-15 million office visits6.5 million hospital days per year80% of hospitalized patients >65<1% in those less than 50Most common Medicare diagnosesMore common in malesAfrican Americans have higher risk
(Hunt et al, 2011)Slide8
Screening
Evaluate potential risk factors with thorough history
Assess patient’s ability to perform ADL’s
Assess fluid volume status, orthostatic BP, BMIScreen for cardiac risk factorsInitial laboratory evaluationTwelve lead electrocardiogramEchocardiogramCoronary arteriography in patients presenting with HF and anginaStress testingSlide9
Risk Factors
Coronary Artery Disease
Myocardial Infarction
Hypertension Valvular Heart DiseaseDiabetes MellitusCardio toxic MedicationsGenetics (Familial cardiomyopathy)Mediastinal RadiationObesity/Metabolic SyndromeRheumatic Heart DiseaseObstructive Sleep ApneaHIVIllicit drugs and ETOHCongenital Heart Defect
Kidney disease
(Hunt et al, 2011) Slide10
Subjective Clinical Findings
Dyspnea at rest worse with exertion
Fatigue
Generalized weaknessExercise IntoleranceFluid Retention, EdemaAbdominal bloating Nocturnal nonproductive coughOrthopneaParoxysmal nocturnal dyspneaWheezing at night with no history of asthma or infectionAnorexia or dull pain right upper quadrant
(
Dunphy
,
Winland
-Brown, Porter & Thomas, 2011)Slide11
Left
vs
Right
(
Zerwekh
,
Claborn
& Miller, 2007)Slide12
Physical Findings
Rales and sometimes wheezing
Peripheral edema
Cool extremitiesAscitesElevated JVDS3 gallop Pre-sacral edemaScrotal EdemaHepatomegalyHypoxemiaPleural effusion and tendernessWorsening mitral or tricuspid regurgitationMay have an arrhythmiaAltered mental status
(
Dunphy
,
Winland
-Brown, Porter & Thomas, 2011)Slide13
Clinical Findings
Congestive Heart Disease, N.D.Slide14
Differential Diagnosis
Pulmonary embolism
Exertional asthma
Cardiac ischemiaCOPDConstrictive pericarditisNephrotic syndromeCirrhosisVenous occlusive diseaseAnemiaSepsisHyperthyroidismPeripheral edema
(Domino, 2011)Slide15
Social Considerations
Alcohol consumption should be no more than 1 glass of wine per day.
Dietary sodium restriction of 2 grams per day or lower is recommended.
Regular exercise should be encouraged as it improves functional status and decreases symptoms. Cardiac rehab is available to assist with this.Abstaining from cigarette smoking and avoidance of second hand smoke is recommended.Immunizations from influenza and pneumococcal vaccine can reduce risk of respiratory infection.Slide16
Laboratory Tests
Complete blood count
Urinalysis
CMP or serum electrolytes to include calcium, magnesium, blood urea nitrogen, serum creatinine, fasting blood glucoseGFRLipid panelLiver Function TestsThyroid Stimulating HormoneSerum natriuretic peptide (BNP)HGA1C Laboratory tests for rheumatologic diseases such as amyloidosis and pheochromocytomaSlide17
Diagnostics
Chest x-ray (PA and lateral)
Two-dimensional echocardiogram is most useful test to determine ejection fraction and valvular abnormalities
Twelve-lead electrocardiogramMaximal Exercise Stress TestingNuclear imaging for estimation of ventricle size, perfusion, and systolic functionCoronary arteriography with angina or ischemiaEndometrial biopsy Holter monitoringElectrophysiology studiesCardiac MRI or transesophageal Doppler 2D echocardiography
Peak flow or
spirometrySlide18
Management
Goal of therapy is to decrease symptoms, hospitalizations, and prevent premature death
Reduce pulmonary venous pressure and congestion
Identify and treat the cause of the heart failure Recognize and treat underlying heart disease or comorbidities such as diabetes hypertension or hyperlipidemiaAdjust diuretics therapy to maintain dry weightRate control for atrial fibrillationEliminate tachycardiaTreat hypertensionPrevent thrombus formation
(
Dunphy
,
Winland
-Brown, Porter & Thomas, 2011)Slide19
Non-Pharmacological
Fluid Restrictions < 2L/day
Low Sodium Diet < 2 g/day
Daily weights after voiding in the morningExercise program and rehabilitation programLifestyle modifications: smoking cessation, alcohol limitations, illicit drug useCoronary RevascularizationValve ReplacementCardiac TransplantResynchronizationImplantable cardioverter-defibrillator (ICD)Biventricular PacingTreat anemia
(McMurray, 2010)Slide20
Pharmacological
Diuretics including loop diuretics, thiazides, potassium-sparing
Angiotensin-converting enzyme (ACE) inhibitors (1
st line with diuretics)Angiotensin-II receptor antagonist- Losartan, ValsartanAldosterone antagonist- (Spironolactone)Hydralazine in combination with nitrateBeta-blockers (1st line therapy in systolic dysfunction)DigoxinCalcium channel blocker (Amlodipine)Vasodilators-nitratesAnticoagulants
Antiplatelets
Inotropic agents (
dobutamine
,
milrinone
)Morphine for acute treatment of associated pulmonary edema
NSAIDS contraindicated
(
Verdecchia
, et al., 2009)Slide21
Complications
Declining functional capacity
Electrolyte disturbances
Acute pulmonary edemaFrequent hospitalizationsAtrial fibrillationLeft ventricular thrombusCerebral embolismSudden death from arrhythmiaRenal failureDeath
(
Owan
et al,
2006)Slide22
Follow Up
Cardiologist Referral is recommend at the onset of symptoms.
The Joint Commission has established mandated core measures for hospitalized patients.
Assessment of left ventricular function with Ejection Fraction (EF) notedIf EF less than 40% patient must be placed on an ACEI or ARBCounseling on smoking cessation must occurDischarge education must include activity level, diet, discharge medications, follw0up appointments, weight monitoring, what to do if symptoms worsen
Upon discharge home, it is recommended that patients have intensive home-care surveillance with home care nurses to decrease the need for hospitalization.
Patients should be seen by their provider within 1 week of discharge and at least every 3 months thereafter.Slide23
Consultation/Referral
Multidisciplinary Team Approach
Refer patients with suspected heart failure and a BNP between 100 and 400
pg/ml to have transthoracic Doppler 2D echocardiography and to see a cardiologist within 2 weeksSeek specialist advise before offering second-line treatment to patients with HF due to left ventricular systolic functionPulmonologistCardiac Rehab ProgramSupport GroupsDieticianHome HealthTransplantHospiceSlide24
References
Aurigemma
, G.P. &
Gaasch, W.H. (2004, September). Diastolic heart failure. The New England Journal of Medicine. 351(11), 1097-1105.Congestive heart disease. (n.d.) Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. (2003). Retrieved January 25 2014 from
http://
medical-dictionary.thefreedictionary.com/Congestive+heart+disease
Domino, F. (2011).
Griffith’s 5 Minute Clinical Consult.
19
th
Ed. Lippincott Williams & Wilkins.
Dunphy
, L. M.,
Winland
-Brown, J. E., Porter, B. O., & Thomas, D. J. (2011).
Primary care: The art
and
science of advanced practice nursing
. (3 ed.). Philadelphia, PA: F.A. Davis Company
.
Hunt, S.A., Abraham, W.T., Chin, M.H., Feldman, A.M., Francis, G.S.,
Ganiats
, T.G., Jessup, M
.,
Konstam
, M.A., ACC/AHA 2005 Guideline update for the diagnosis and treatment of heart failure
adult
: A report of the American College of Cardiology/American Heart Association Task Force
on practice
guidelines: Developed in collaboration with the American College of Chest
Physician and
the
International
Society for heart and lung transplantation. Circulation, 2005, 112, 154-235.
doi
://10.1161/CIRCULATIONAHA.105.167586
.
Homma, S., Thompson, J.L.,
Pullicino
, P.M., Levin, B.,
Freudenberger
, R.S.,
Teerlink
, J.R., Ammon, S
Graham, S., Sacco, R.L., Mann, D.L., Mohr, J.P., Massie, B.M.,
Labovitz
, A.J., Anker, S.D.,
Lok
,
D.J.,
Ponikowski
, P.,
Estol
, C.J., Lip, G., Di
Tullio
, M.R., Sanford, A.R., Mejia, V., Gabriel, A.P.,
Valle, M.L., &
Buchsbaum
, R. (2012, May). Warfarin and aspirin in patients with heart failure and
sinus rhythm.
The New England Journal of Medicine.
366(20), 1859-1869.
McMurray, J.V. (2010). Systolic heart failure.
The New England Journal of Medicine.
362(3), 228-38.Slide25
References
Owan
, T.E., Hodge, D.O.,
Herges, R.M., Jacobsen, S.J., Roger, V.L., & Redfield, M.M. (2006, June). Trends in prevalence and outcome of heart failure with preserved ejection fraction. The New England Journal of Medicine. 355(3). 251-259.Verdecchia, P., Angeli, F., Cavallini, C., Gattobigio
, R., Gentile, G.,
Staessen
, J. A., et al. (2009). Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: A meta-analysis.
European Heart Journal
, 679-688
.
Zerwekh
, J.,
Claborn
, J. C., & Miller, C. J. (2007).
Memory notebook of nursing
. (4 ed., Vol. 2).
New York
, NY: Nursing Education Consultants.Slide26
Questions
1
. The treatment goals for HF include:
Improve symptoms Optimize fluid volume statusRestore normal oxygenationIdentify and treat etiologyE. All the above2. The practitioner should pay particular attention to the presence of which of the following findings that suggest HF on the physical exam:
Elevated JVD
Peripheral edema
Third heart beat
Diminished lung sounds
Both A and C
All of the aboveSlide27
Questions
Patients that have heart failure with an ejection fraction >50% are classified as:
Systolic heart failure
Diastolic heart failureHow would a patient that has dyspnea on less-than ordinary exertion would be classified according to the NYHA NYHA Class INYHA Class IINYHA Class IIINYHA Class IV
5. The most useful diagnostic test to evaluate patients with heart failure is:
CXR
Stress Test
2-D echocardiogramSlide28
6.
The following would be a contraindication in ACEI except:
Angioedema
HypernatremiaSerum creatinine > 3.0Hyperkalemia >5.57. Which medication classification can be substituted for ACEI:Beta-blockersVasodilatorAngiotensin II Receptor BlockerAldosterone antagonists
8. Patients taking aldosterone antagonists require frequent monitoring for:
Increased edema
Worsening HF
Hyperkalemia
Hypotension
QuestionsSlide29
Questions
Patients taking diuretics should be monitored frequently for:
Renal dysfunction
Electrolyte abnormalitiesSymptomatic hypotensionGoutAll of the above10. Diuretics should be administered at doses high enough to:Allow the patient to eat and drink whatever they want
Improve signs and symptoms of congestion
Reduce blood pressure enough that a ACEI will not be required